Kidney Support in Children using an Ultrafiltration Device: A Multicenter, Retrospective Study.

BACKGROUND AND OBJECTIVES Provision of kidney replacement therapy (KRT) to manage kidney injury and volume overload in critically ill neonates and small children is technically challenging. The use of machines designed for adult-sized patients, necessitates large catheters, a high extracorporeal volume relative to patient size, and need for blood priming. The Aquadex FlexFlow System (CHF Solutions Inc., Eden Prairie, MN) is an ultrafiltration device designed for fluid removal in adults with diuretic resistant heart failure. It has an extracorporeal volume of 33 ml, which can potentially mitigate some complications seen at onset of KRT in smaller infants. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS In this multicenter, retrospective case series of children who received KRT with an ultrafiltration device (n=119 admissions, 884 circuits), we report demographics, circuit characteristics, complications, and short- and long-term outcomes. Patients were grouped according to weight (<10, 10-20, and >20 kg), and received one of three modalities: slow continuous ultrafiltration, continuous venovenous hemofiltration (CVVH), or prolonged intermittent KRT. Our primary outcome was survival to end of KRT. RESULTS Treatment patterns and outcomes varied between the groups. In patients who weighed <10 kg, the primary indication was AKI in 40%, volume overload in 46%, and ESKD in 14%. These patients primarily received CVVH (66%, n=48) and prolonged intermittent KRT (21%, n=15). In the group weighing >20 kg, volume overload was the primary indication in 91% and slow continuous ultrafiltration was the most common modality. Patients <10 kg had lower KRT survival than those >20 kg (60% versus 97%), more volume overload at onset, and received KRT for a longer duration. Cardiovascular complications at initiation were seen in 3% of treatments and none were severe. Complications during therapy were seen in 15% treatments and most were vascular access-related. CONCLUSIONS We report the first pediatric experience using an ultrafiltration device to provide a range of therapies, including CVVH, prolonged intermittent KRT, and slow continuous ultrafiltration. We were able to initiate KRT with minimal complications, particularly in critically ill neonates. There is an unmet need for devices specifically designed for younger patients. Having size-appropriate machines will improve the care of smaller children who require kidney support.

[1]  H. Sugawara,et al.  Complications During Continuous Renal Replacement Therapy in Critically Ill Neonates , 2019, Blood Purification.

[2]  Craig S. Wong,et al.  Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study , 2017, The Lancet. Child & adolescent health.

[3]  Q. Mok,et al.  Continuous Venovenous Hemofiltration in Children Less Than or Equal to 10 kg: A Single-Center Experience , 2017, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[4]  Rajit K. Basu,et al.  Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults , 2017, The New England journal of medicine.

[5]  E. Beierle,et al.  Outcome assessment of renal replacement therapy in neonates. , 2016, The Journal of surgical research.

[6]  Puneet Bhatla,et al.  Novel Use of an Ultrafiltration Device as an Alternative Method for Fluid Removal in Critically Ill Pediatric Patients with Cardiac Disease: A Case Series , 2016, Pediatric reports.

[7]  C. Ronco,et al.  CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations , 2016, Pediatric Nephrology.

[8]  Rajit K. Basu,et al.  Urinary biomarker incorporation into the renal angina index early in intensive care unit admission optimizes acute kidney injury prediction in critically ill children: a prospective cohort study. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  G. Fonarow,et al.  Aquapheresis Versus Intravenous Diuretics and Hospitalizations for Heart Failure. , 2016, JACC. Heart failure.

[10]  S. Goldstein,et al.  The role of fluid overload in the prediction of outcome in acute kidney injury , 2016, Pediatric Nephrology.

[11]  D. Askenazi,et al.  Smaller circuits for smaller patients: improving renal support therapy with Aquadex™ , 2016, Pediatric Nephrology.

[12]  P. Armand,et al.  L’aquaphérèse, une technique innovante en cardiologie , 2015 .

[13]  David Boutarin,et al.  [Aquapheresis, an innovative technique in cardiology]. , 2015, Revue de l'infirmiere.

[14]  Malcolm G. Coulthard,et al.  Haemodialysing babies weighing <8 kg with the Newcastle infant dialysis and ultrafiltration system (Nidus): comparison with peritoneal and conventional haemodialysis , 2014, Pediatric Nephrology.

[15]  F. Schaefer,et al.  Survival and clinical outcomes of children starting renal replacement therapy in the neonatal period. , 2014, Kidney international.

[16]  C. Ronco,et al.  Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM) , 2014, The Lancet.

[17]  J. Fortenberry,et al.  Continuous renal replacement therapy for children ≤10 kg: a report from the prospective pediatric continuous renal replacement therapy registry. , 2013, The Journal of pediatrics.

[18]  S. Goldstein,et al.  Fluid overload is associated with impaired oxygenation and morbidity in critically ill children* , 2012, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[19]  S. Sutherland,et al.  Continuous renal replacement therapy in children , 2012, Pediatric Nephrology.

[20]  Y. Han,et al.  Weight-based determination of fluid overload status and mortality in pediatric intensive care unit patients requiring continuous renal replacement therapy , 2011, Intensive Care Medicine.

[21]  C. Mache,et al.  One-year safe use of the Prismaflex HF20® disposable set in infants in 220 renal replacement treatment sessions , 2011, Intensive Care Medicine.

[22]  S. Goldstein,et al.  A standard, noninvasive monitoring of hematocrit algorithm improves blood pressure control in pediatric hemodialysis patients. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[23]  S. L. Goldstein,et al.  Evaluation of the PRISMA M10® Circuit in Critically Ill Infants with Acute Kidney Injury: A Report from the Prospective Pediatric CRRT Registry Group , 2006, The International journal of artificial organs.

[24]  J. Fortenberry,et al.  Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  S. Goldstein,et al.  Blood volume monitoring to achieve target weight in pediatric hemodialysis patients , 2004, Pediatric Nephrology.

[26]  S. Goldstein,et al.  Continuous renal replacement therapy in children up to 10 kg. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.